Sino Biopharmaceutical Limited (HKG:1177)
8.44
-0.35 (-3.98%)
Sep 11, 2025, 4:08 PM HKT
Sino Biopharmaceutical Market Cap
Sino Biopharmaceutical has a market cap or net worth of 150.95 billion as of September 11, 2025. Its market cap has increased by 155.12% in one year.
Market Cap
150.95B
Enterprise Value
155.92B
Revenue
33.49B
Ranking
n/a
PE Ratio
35.77
Stock Price
8.44
Market Cap Chart
Since September 29, 2000, Sino Biopharmaceutical's market cap has increased from 329.97M to 150.95B, an increase of 45,645.08%. That is a compound annual growth rate of 27.81%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 10, 2025 | 157.21B | 169.85% |
Dec 31, 2024 | 58.26B | -8.75% |
Dec 29, 2023 | 63.85B | -24.41% |
Dec 30, 2022 | 84.46B | -17.53% |
Dec 31, 2021 | 102.41B | -27.33% |
Dec 31, 2020 | 140.92B | 3.10% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
BeOne Medicines AG | 300.88B |
Hansoh Pharmaceutical Group Company | 234.28B |
JD Health International | 214.82B |
Innovent Biologics | 172.82B |
WuXi Biologics | 152.81B |
Akeso | 129.05B |
CSPC Pharmaceutical Group | 127.14B |
Sichuan Kelun-Biotech Biopharmaceutical | 119.64B |